Top Biotech Companies (3,701)
CytoAgents is a biotechnology company focused on the the treatment of COVID-19, Influenza and other viral infectious diseases.
Future Fields is a fly biotechnology company based in Edmonton, Canada. Founded in 2018, Future Fields is on a mission to change how we do science for humanity and the planet. Our biomanufacturing platform, the EntoEngine™, is the first synthetic biology system in the world to use fruit flies for recombinant protein production. Powered by people and fly by design,...
Singular Genomics is a venture capital backed biotech company in La Jolla, California. We foster a dynamic, fast paced, result oriented environment where we offer employees the opportunity to make a significant impact in a rapidly expanding company. Singular Genomics is inventing at the forefront of genomics, one of the world’s fastest growing industries. We are located in the center...
Inflammatix is developing an innovative point-of-care instrument platform to be used with a test to aid in the diagnosis of acute infection and sepsis by harnessing the immune system to deliver advanced immune response diagnostics. Our test rapidly informs the clinician about the likelihood of bacterial or viral infection and the need for ICU level care in the emergency department....
Birmingham Biotech offers a wide variety of in vitro diagnostic solutions, medical devices and equipment to the global medical community at a markedly low cost. We aim to assist healthcare professionals and modernise healthcare systems around the world by focusing on capability building for our clients
PolyActiva is an innovative clinical-stage ophthalmology company with a unique proprietary polymeric prodrug technology that enables site-specific, precise and controlled drug delivery to the eye. With the PolyActiva technology, exceptional zero-order release profiles are achieved over treatment periods ranging from 6 to 12 months. Our mission is to become a leader in ophthalmic medicine by providing unique biodegradable implants with...
String’s purpose is to commercialize next generation ingredients that enable sustainability and traceability in evolving value chains. String Bio is in the business of manufacturing raw materials for Animal Nutrition, Agriculture, Human Nutrition and Personal Care sectors that are derived using a sustainable and traceable process. String, as one of the world leaders in gas fermentation, has a strong IP...
Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions so that customers can acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, precision research mouse models, and integrated model design and breeding services, Taconic operates...
Zedsen’s proprietary, non-invasive sensor aims to change the current paradigm of health and oncological care for the better. We are committed to addressing the Institute for Healthcare Improvement’s “Triple Aim'' for optimising healthcare systems, by enhancing the quality of care, improving the health of the overall patient population, and decreasing the cost of healthcare per capita
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
3Bar Biologics delivers a sustainable microbe inoculant system that helps farmers increase crop yield.
Nobel Prize winning light harvesting materials delivering High Sensitivity Fluorescence in diagnostic and Life Science applications
Resolution Therapeutics is a biotechnology company developing macrophage cell therapy to treat inflammatory organ disease. The company was founded following a productive collaboration between Edinburgh’s Centre for Regenerative Medicine, the Scottish National Blood Transfusion Service, and Syncona Investment Management Limited. The company is based in the Centre for Regenerative Medicine on the Edinburgh Royal Infirmary Campus, and is backed by...
Emerald Heath Pharmaceuticals is a biotech company developing novel therapies for neurodegenerative and autoimmune diseases. Including multiple sclerosis, systemic sclerosis (a form of scleroderma), Parkinson's disease and Huntington's disease. References/Sources: - National Multiple Sclerosis Society - Parkinson’s Foundation - Huntington’s Disease Society of America - Scleroderma Foundation - Global Multiple Sclerosis Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive...
Hemostemix is a public clinical-stage company that develops and commercializes innovative blood-derived cell therapies for medical conditions that are not adequately addressed by current treatments. For more information, please visit www.hemostemix.com.
Loam works with 4.5 billion years of evolution to solve the climate crisis. Microbes have changed the composition of our atmosphere through earth’s history. At Loam, we are ensuring these organisms can do it again. Through a better understanding of how microbes influence the carbon cycle, we can create new planetary-scale opportunities for carbon sequestration and improve agricultural productivity.
Advanced BioScience Laboratories, Inc (ABL) is a leading contract research and manufacturing organization, that partners with our clients to support their vaccine and therapeutic development programs. We offer a unique combination of preclinical and clinical services designed to first address the scientific challenges often encountered during proof-of-concept, and then streamline process development and cGMP production of clinical supply. ABL can assist...
Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines (excluding RNAi therapeutics) to treat human disease in ways that were not previously possible. We’re building a first-in-kind platform designed to sit at the intersection of RNA technology delivery methods, data science and automation to develop an expansive portfolio of medicines, initially focused in the...
